Are patients with IBD knowledgeable about the risks of their medications?
Keohane
John
J
Department of Medicine, Alimentary Pharmabiotic Centre, University College Cork, Cork, Ireland.
Shanahan
Fergus
F
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000627:therapeutic use; D007722:Health Knowledge, Attitudes, Practice; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy* / Q000523:psychology*; D010349:Patient Compliance; D010353:Patient Education as Topic
D000894:Anti-Inflammatory Agents, Non-Steroidal; D000911:Antibodies, Monoclonal; D007166:Immunosuppressive Agents